M
Matthew P. Fox
Researcher at Boston University
Publications - 337
Citations - 14658
Matthew P. Fox is an academic researcher from Boston University. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 57, co-authored 300 publications receiving 12378 citations. Previous affiliations of Matthew P. Fox include University of Minnesota & University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
Kaposi sarcoma-associated herpes virus and response to antiretroviral therapy: a prospective study of HIV-infected adults.
TL;DR: In a population with a high KSHV prevalence, HIV-positive adults coinfected with KSHv achieved similar immunologic and virologic responses to ART early after treatment initiation compared with those with K SHV−.
Journal ArticleDOI
Risk of ischemic placental disease is increased following in vitro fertilization with oocyte donation: a retrospective cohort study.
Anna M. Modest,Anna M. Modest,Katherine M. Johnson,S. Ananth Karumanchi,S. Ananth Karumanchi,Nina Resetkova,Brett C. Young,Matthew P. Fox,Lauren A. Wise,Michele R. Hacker,Michele R. Hacker +10 more
TL;DR: Pregnancies conceived using donor IVf and autologous IVF were at higher risk of IPD and its associated conditions than non-IVF pregnancies and associations were consistently stronger for donor IVF pregnancies.
Journal ArticleDOI
Addressing Measurement Error in Random Forests Using Quantitative Bias Analysis.
TL;DR: In this paper, the impact of measurement error on the performance of random-forest models and variable importance is quantified using a quantitative bias analysis approach using data from the National Comorbidity Survey Replication (NCSR).
Journal ArticleDOI
Developing a predictive risk model for first-line antiretroviral therapy failure in South Africa
Julia Rohr,Prudence Ive,C. Robert Horsburgh,Rebecca Berhanu,Kate Shearer,Mhairi Maskew,Lawrence Long,Ian Sanne,Jean Bassett,Osman Ebrahim,Matthew P. Fox,Matthew P. Fox +11 more
TL;DR: A predictive model is developed to identify patients at the greatest risk of virologic failure on first‐line antiretroviral therapy, and to estimate the proportion of patients needing second‐line ART over five years on treatment.
Journal ArticleDOI
Clinical predictor score to identify patients at risk of poor viral load suppression at six months on antiretroviral therapy: results from a prospective cohort study in Johannesburg, South Africa.
M. Mbengue,Charles Chasela,Charles Chasela,Dorina Onoya,Souleymane Mboup,Matthew P. Fox,Denise Evans +6 more
TL;DR: The findings suggest a 6-month CPS may have the potential to identify patients at risk of poor viral load suppression, and may be used to target patients who need intensive adherence support, with the caveat that there may be a three- to four-fold increase in the pool of patients identified for adherence counseling.